Skip to main content
AK Medical Holdings Limited logo

AK Medical Holdings Limited — Investor Relations & Filings

Ticker · 1789 ISIN · KYG020141019 HKEX Manufacturing
Filings indexed 306 across all filing types
Latest filing 2026-06-05 Transaction in Own Shar…
Country HK Hong Kong
Listing HKEX 1789

About AK Medical Holdings Limited

http://www.ak-medical.net

AK Medical Holdings Limited is a specialized medical device company focused on the design, development, production, and marketing of orthopedic implants, including joint, spinal, and trauma products. The company is a global pioneer in applying advanced manufacturing techniques to orthopedic solutions. It was the world's first to commercialize and apply metal additive manufacturing (3D printing/3D ACT) technology for joint replacement and spine care, enabling the precise construction of trabecular-like structures to promote osseointegration and extend implant lifespan. AK Medical also provides comprehensive orthopedic intelligent equipment, such as the Visual Treatment Solution, which integrates 3D surgical planning software and intelligent surgical robots for enhanced precision. Additionally, the company offers full-process personalized customization services (ICOS) to meet individual patient needs and utilizes proprietary Supravit® HA coating applied via Plasma Vacuum Spraying (VPS) for improved implant stability and bone fusion.

Recent filings

Filing Released Lang Actions
Next Day Disclosure Return
Transaction in Own Shares Classification · 93% confidence The document is a Form FF305 Next Day Disclosure Return filed under Hong Kong Main Board/GEM rules detailing changes in issued shares and extensive records of share repurchases for cancellation and on-market purchase details. This is a company reporting transactions in its own shares (buybacks and treasury share movements), matching the "Transaction in Own Shares" category.
2026-06-05 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 85% confidence The document is a Hong Kong Stock Exchange Next Day Disclosure Return (Form FF305) under Main Board Rule 13.25A/GEM Rule 17.27A and related rules, detailing actual changes in issued shares and treasury shares, including on-market repurchases and sales. It is not a general report announcement or regulatory filing in the fallback sense, nor is it a capital-raising update, but rather a detailed report of the company’s own share transactions (buybacks and treasury sales). This matches the “Transaction in Own Shares” category.
2026-06-04 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 88% confidence The document is a Next Day Disclosure Return (Form FF305) under Hong Kong Stock Exchange listing rules detailing changes in issued shares, treasury shares and, notably, a detailed repurchase report of own shares (Sections I and II), including dates, volumes and prices. This corresponds directly to a company’s report on buying back its own shares. According to our taxonomy, that fits “Transaction in Own Shares” (Code: POS).
2026-06-03 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 90% confidence The document is Hong Kong Stock Exchange Form FF305 “Next Day Disclosure Return” detailing changes in issued and treasury shares, and summarizing the company’s on-market share repurchases (dates, volumes, prices) under Main Board/GEM Rules. This is a regulatory announcement of share buybacks and sales of treasury shares, matching the “Transaction in Own Shares” category.
2026-06-02 English
(Revised) Next Day Disclosure Return
Transaction in Own Shares Classification · 93% confidence The document is a Next Day Disclosure Return (Form FF305) filed under HKEx rules providing detailed tables of changes in issued shares, treasury shares, and on-market repurchases of the company’s own shares. It includes repurchase dates, prices, totals, confirmations of compliance, and repurchase mandate details. This is not an AGM presentation, earnings release, or a regulatory announcement only linking to another report. It is a full disclosure of the company’s share repurchase activity and changes in issued capital. According to the filing definitions, this corresponds to a Transaction in Own Shares (POS).
2026-06-02 English
Next Day Disclosure Return
Transaction in Own Shares Classification · 93% confidence The document is a FF305 Next Day Disclosure Return filed under the Hong Kong Listing Rules detailing changes in issued shares, treasury shares, and share repurchases on-market. It is specifically a report of the company’s own-share transactions (repurchases for cancellation and sale of treasury shares). This matches the definition for Transaction in Own Shares (POS).
2026-06-01 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.